🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study was to evaluate the efficacy, safety and tolerability...
Status
Not Yet Recruiting
Location
Breast Cancer Center Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences
Start Date
2025-08-01
Trial ID
NCT07093931
Treatments Being Tested
The goal of this clinical trial is to compare two treatment regimes, namely...
Status
Recruiting
Location
Tata Memorial Centre
Start Date
2024-03-07
Trial ID
NCT06214572
This is a Phase 3, randomized, double-blind clinical trial aimed at evaluat...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2025-06-11
Trial ID
NCT06953999
The investigators conducted a phase II, prospective, two-arm clinical study...
Status
Unknown
Location
Fujian Medical University Union Hospital
Start Date
2023-05-25
Trial ID
NCT05821452
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00436709
This study will evaluate the efficacy and safety of trastuzumab deruxtecan ...
Status
Active Not Recruiting
Location
Instituto Medico Especializado Alexander Fleming
Start Date
2021-05-21
Trial ID
NCT04704934
Treatments Being Tested
The investigators preliminary data suggests that FOLFOX-A may have equal or...
Status
Completed
Location
Roxanne Wood
Start Date
2014-02-01
Trial ID
NCT02022033
Treatments Being Tested
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
This is a multicenter, double-blind, randomized, phase 2 trial to investiga...
Status
Recruiting
Location
The fourth hospital of Hebei Medical University
Start Date
2024-11-15
Trial ID
NCT06576921
Treatments Being Tested
Quisinostat besides its own efficacy, which can potentially lead to better ...
Status
Completed
Location
Russian Oncological Research Center n.a. N. N. Blokhin RAMS
Start Date
2013-08
Trial ID
NCT02728492
Treatments Being Tested